1 |
18f-av-1451 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
2 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
3 |
18f-ro6958948 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
4 |
4-benzyl-2-naphtalen-1-yl-1,2,4-thiadiazolidine-3,5-dione |
- |
- |
- |
- |
005 1件: 5 💬 |
5 |
[18f]florbetapir |
- |
- |
- |
- |
005 1件: 5 💬 |
6 |
[18f]mni-815 (mni-815) |
- |
- |
- |
- |
005 1件: 5 💬 |
7 |
[18f]mni-952 |
- |
- |
- |
- |
005 1件: 5 💬 |
8 |
[18f]mni-958 |
- |
- |
- |
- |
005 1件: 5 💬 |
9 |
[18f]t807 ([18f]mni-777) |
- |
- |
- |
- |
005 2件: 5 , 6 💬 |
10 |
[f18]-fddnp |
- |
- |
- |
- |
005 1件: 5 💬 |
11 |
Ab1010 |
- |
- |
- |
- |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
12 |
Abbv-8e12 |
- |
- |
- |
- |
005 2件: 5 , 7 💬 |
13 |
Al |
- |
- |
- |
- |
005 9件: 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
14 |
Al-108 |
- |
- |
- |
- |
005 1件: 5 💬 |
15 |
Alpha-lipoic acid and l-acetyl carnitine |
Levocarnitine |
5件: D00048 D00048, D00086 D00086, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 1件: 5 💬 |
16 |
Anti-parkinson medication |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 8 , 17 💬 |
17 |
Antisense oligonucleotide |
- |
- |
- |
- |
005 1件: 5 💬 |
18 |
Ask nr. 21972 |
- |
- |
- |
- |
005 1件: 5 💬 |
19 |
Azilect |
- |
- |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
20 |
Azp2006 oral solution |
- |
- |
- |
- |
005 1件: 5 💬 |
21 |
Balance |
Isoxaflutole |
- |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
22 |
Bepranemab |
- |
- |
- |
- |
005 1件: 5 💬 |
23 |
Biib092 |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
24 |
Bms-986168 |
Gosuranemab |
1件: D11293 D11293 💬 |
MAPT 1件: MAPT 💬 |
Alzheimer disease 4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases |
005 1件: 5 💬 |
25 |
Bms986168 |
- |
- |
- |
- |
005 1件: 5 💬 |
26 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
27 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
28 |
Coenzym q10 nanodispersion |
- |
- |
- |
- |
005 1件: 5 💬 |
29 |
Coenzym q10, ubiquinon, ubichinon |
- |
- |
- |
- |
005 1件: 5 💬 |
30 |
Coenzyme q10 |
Ubidecarenone |
1件: D01065 D01065 💬 |
- |
- |
002 12件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
31 |
Coq10 |
- |
- |
- |
- |
005 3件: 5 , 6 , 8 💬 |
32 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
33 |
Datscan |
- |
- |
- |
- |
002 4件: 2 , 5 , 6 , 17 💬 |
34 |
Datscan™ ioflupane (123i) injection |
- |
- |
- |
- |
005 3件: 5 , 6 , 17 💬 |
35 |
Davunetide |
Davunetide |
1件: D09401 D09401 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
36 |
Davunetide (al-108, nap) |
Davunetide |
1件: D09401 D09401 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
37 |
Device: deep brain stimulation |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 8 , 17 💬 |
38 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
39 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
40 |
Diagnostic test: flutemetamol f18 injection |
Flutemetamol |
1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
41 |
Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau |
- |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
42 |
Donepezil |
Donepezil |
2件: D00670 D00670, D07869 D07869 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 9件: 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
43 |
Droxidopa |
Droxidopa |
1件: D01277 D01277 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
005 3件: 5 , 6 , 17 💬 |
44 |
Emeramide |
Emeramide |
- |
- |
- |
005 2件: 5 , 17 💬 |
45 |
Exelon 1,5 mg hartkapseln |
- |
- |
- |
- |
005 1件: 5 💬 |
46 |
Exelon 3,0 mg hartkapseln |
- |
- |
- |
- |
005 1件: 5 💬 |
47 |
Exelon 6,0 mg hartkapseln |
- |
- |
- |
- |
005 1件: 5 💬 |
48 |
F-18 |
- |
- |
- |
- |
005 2件: 5 , 127 💬 |
49 |
F-18 av 1451 |
- |
- |
- |
- |
005 1件: 5 💬 |
50 |
Flortaucipir |
Flortaucipir |
1件: D11210 D11210 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
51 |
Flortaucipir f18 |
Flortaucipir |
1件: D11210 D11210 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
52 |
Flutemetamol |
Flutemetamol |
- |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
53 |
Flutemetamol f18 |
Flutemetamol |
1件: D10231 D10231 💬 |
- |
- |
005 5件: 5 , 6 , 7 , 17, 127 💬 |
54 |
Fresh frozen plasma |
- |
- |
- |
- |
005 1件: 5 💬 |
55 |
Gdnf & synchro med infusion system |
- |
- |
- |
- |
005 1件: 5 💬 |
56 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
57 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 7件: 5 , 6 , 13, 17, 83, 97, 226 💬 |
58 |
Leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 10件: 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
59 |
Lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 5件: 2 , 5 , 13, 14, 20 💬 |
60 |
Lithium |
- |
- |
- |
- |
002 5件: 2 , 5 , 6 , 7 , 8 💬 |
61 |
Masitinib |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
62 |
Masitinib 100mg |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 2件: 2 , 5 💬 |
63 |
Masitinib 200mg |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 2件: 2 , 5 💬 |
64 |
Masitinib mesylate |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
65 |
N1,n3-bis(2-mercaptoethyl) isophthalamide |
- |
- |
- |
- |
005 2件: 5 , 17 💬 |
66 |
Nbmi |
- |
- |
- |
- |
005 2件: 5 , 17 💬 |
67 |
Niacinamide |
Nicotinamide |
1件: D00036 D00036 💬 |
- |
- |
005 4件: 5 , 6 , 13, 67 💬 |
68 |
Nitrogen |
Nitrogen |
1件: D00083 D00083 💬 |
- |
- |
005 6件: 5 , 6 , 17, 171, 211, 299 💬 |
69 |
Np031112 |
- |
- |
- |
- |
005 1件: 5 💬 |
70 |
Np031112 600mg |
- |
- |
- |
- |
005 1件: 5 💬 |
71 |
Np031112 800mg |
- |
- |
- |
- |
005 1件: 5 💬 |
72 |
Nt 101 |
- |
- |
- |
- |
005 4件: 5 , 6 , 7 , 17 💬 |
73 |
Other: 13c6 leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
74 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
75 |
Procedure: brain pet scan |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
76 |
Pyruvate, creatine, niacinamide |
Creatine |
1件: D00036 D00036 💬 |
- |
- |
005 1件: 5 💬 |
77 |
Raclopride |
Raclopride |
- |
- |
- |
005 4件: 5 , 6 , 7 , 17 💬 |
78 |
Radiopharmaceuticals |
- |
- |
- |
- |
005 1件: 5 💬 |
79 |
Rasagilin |
- |
- |
- |
- |
005 2件: 5 , 6 💬 |
80 |
Rasagiline |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 4件: 2 , 5 , 6 , 17 💬 |
81 |
Rasagiline mesilate |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 3件: 2 , 5 , 6 💬 |
82 |
Riluzole |
Riluzole |
1件: D00775 D00775 💬 |
GRIA1 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 8件: 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
83 |
Rivastigmine |
Rivastigmine |
2件: D02558 D02558, D03822 D03822 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
005 3件: 5 , 6 , 13 💬 |
84 |
Salsalate |
Salsalate |
1件: D00428 D00428 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
005 1件: 5 💬 |
85 |
Single dose c2n-8e12 |
- |
- |
- |
- |
005 1件: 5 💬 |
86 |
Stem cell therapy |
- |
- |
- |
- |
005 1件: 5 💬 |
87 |
Sugar pill |
- |
- |
- |
- |
005 8件: 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
88 |
Suvorexant |
Suvorexant |
1件: D10082 D10082 💬 |
HCRTR1 2件: HCRTR1, HCRTR2 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
005 3件: 5 , 6 , 13 💬 |
89 |
Tideglusib |
Tideglusib |
- |
- |
- |
005 2件: 5 , 113 💬 |
90 |
Tolfenamic acid |
Tolfenamic acid |
1件: D01183 D01183 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
005 1件: 5 💬 |
91 |
Tpi 287 2 mg/m2 |
- |
- |
- |
- |
005 2件: 5 , 7 💬 |
92 |
Tpi-287 20 mg/m2 |
- |
- |
- |
- |
005 2件: 5 , 7 💬 |
93 |
Tpi-287 6.3 mg/m2 |
- |
- |
- |
- |
005 2件: 5 , 7 💬 |
94 |
Trihexyphenidyl |
Trihexyphenidyl |
2件: D00787 D00787, D08638 D08638 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
005 2件: 5 , 6 💬 |
95 |
Ubidecarenon |
- |
- |
- |
- |
005 1件: 5 💬 |
96 |
Ucb0107 (bepranemab) |
- |
- |
- |
- |
005 1件: 5 💬 |
97 |
Valproic acid |
Valproic acid |
1件: D00399 D00399 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 10件: 3 , 5 , 26, 34, 65, 89, 90, 222, 256, 331 💬 |
98 |
Vizamyl |
- |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
99 |
Vizamyl (flutemetamol(f-18)) |
Flutemetamol |
- |
- |
- |
005 3件: 5 , 7 , 127 💬 |
100 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
101 |
Xeomin |
- |
- |
- |
- |
005 7件: 5 , 6 , 7 , 13, 15, 17, 113 💬 |
102 |
Zolpidem |
Zolpidem |
2件: D00706 D00706, D08690 D08690 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 3件: 5 , 6 , 46 💬 |